Business Description
Redsense Medical AB
ISIN : SE0006965158
Total Employee Number:
5Compare
Compare
Traded in other countries / regions
REDS.SwedenR0Z.GermanyRDSNF.USA IPO Date
2023-02-16Description
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.89 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 10.72 | |||||
Beneish M-Score | -3.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EBITDA Growth Rate | 13.3 | |||||
3-Year EPS without NRI Growth Rate | 3.1 | |||||
3-Year FCF Growth Rate | 17.4 | |||||
3-Year Book Growth Rate | 2.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.39 | |||||
Quick Ratio | 3.27 | |||||
Cash Ratio | 2.22 | |||||
Days Inventory | 398.6 | |||||
Days Sales Outstanding | 52.04 | |||||
Days Payable | 102.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.11 | |||||
Operating Margin % | -12.22 | |||||
Net Margin % | -11.31 | |||||
EBITDA Margin % | -8.46 | |||||
FCF Margin % | -24.59 | |||||
OCF Margin % | -12.59 | |||||
ROE % | -8.1 | |||||
ROA % | -7.3 | |||||
ROIC % | -12.19 | |||||
3-Year ROIIC % | 26.46 | |||||
ROC (Joel Greenblatt) % | -37.75 | |||||
ROCE % | -8.75 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 46.36 | |||||
PS Ratio | 2.59 | |||||
PB Ratio | 1.89 | |||||
Price-to-Tangible-Book | 3.4 | |||||
EV-to-EBIT | -18.14 | |||||
EV-to-EBITDA | -26.2 | |||||
EV-to-Revenue | 2.22 | |||||
EV-to-FCF | -9.04 | |||||
Price-to-GF-Value | 0.6 | |||||
| Price-to-Net-Current-Asset-Value | 3.4 | |||||
| Price-to-Net-Cash | 12.75 | |||||
Earnings Yield (Greenblatt) % | -5.51 | |||||
FCF Yield % | -9.45 |
Redsense Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Redsense Medical AB Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-18 | In 142 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 51 days | ||
| General meeting for 2026 | 2026-05-20 16:30 | 0.51 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.51 (+0.00%) | ||
| Annual report for 2025 | 2026-04-08 | 0.51 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-19 | 0.51 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 0.51 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-20 | 0.51 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-28 | 0.51 (+0.00%) | ||
| General meeting for 2024 | 2025-05-14 | 0.51 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:RDSNF
No articles.
Press Release
Articles on Redsense Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers